Savaysa

prophylaxis of systemic embolism, Cerebrovascular accident prophylaxis, Pulmonary Embolism + 4 more
Treatment
7 FDA approvals
20 Active Studies for Savaysa

What is Savaysa

EdoxabanThe Generic name of this drug
Treatment SummaryEdoxaban is a type of medicine called a Novel Oral Anti-Coagulant (NOAC). It helps prevent blood clots by inhibiting a key protein in the coagulation cascade, called factor Xa. It is used to reduce the risk of stroke in people with nonvalvular atrial fibrillation and to treat deep vein thrombosis and pulmonary embolism. Edoxaban is preferred over warfarin because it starts working quickly, is easier to take and monitor, and has fewer side effects.
Savaysais the brand name
image of different drug pills on a surface
Savaysa Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Savaysa
Edoxaban
2015
3

Approved as Treatment by the FDA

Edoxaban, otherwise called Savaysa, is approved by the FDA for 7 uses including prophylaxis of systemic embolism and Atrial Fibrillation .
prophylaxis of systemic embolism
Atrial Fibrillation
Deep Vein Thrombosis
Pulmonary Embolism
Cerebrovascular accident prophylaxis
Stroke
Systemic Embolism

Effectiveness

How Savaysa Affects PatientsEdoxaban increases the time it takes for blood to clot, as measured by tests such as aPTT, PT, and INR.
How Savaysa works in the bodyEdoxaban stops a chemical reaction in the body that helps create a blood clot. It specifically stops the enzyme factor Xa from working, which prevents clotting.

When to interrupt dosage

The advised dose of Savaysa is contingent upon the identified condition, including Deep Vein Thrombosis, Cerebrovascular accident prophylaxis and Deep Vein Thrombosis (DVT). The measure of dosage fluctuates as per the procedure of delivery outlined in the table underneath.
Condition
Dosage
Administration
Stroke
, 15.0 mg, 30.0 mg, 60.0 mg
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral
Atrial Fibrillation
, 15.0 mg, 30.0 mg, 60.0 mg
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral
Pulmonary Embolism
, 15.0 mg, 30.0 mg, 60.0 mg
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral
Deep Vein Thrombosis
, 15.0 mg, 30.0 mg, 60.0 mg
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral
prophylaxis of systemic embolism
, 15.0 mg, 30.0 mg, 60.0 mg
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral
Cerebrovascular accident prophylaxis
, 15.0 mg, 30.0 mg, 60.0 mg
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral
Systemic Embolism
, 15.0 mg, 30.0 mg, 60.0 mg
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral

Warnings

Savaysa Contraindications
Condition
Risk Level
Notes
Hemorrhage
Do Not Combine
There are 20 known major drug interactions with Savaysa.
Common Savaysa Drug Interactions
Drug Name
Risk Level
Description
(R)-warfarin
Major
The risk or severity of bleeding can be increased when Edoxaban is combined with (R)-warfarin.
(S)-Warfarin
Major
The risk or severity of bleeding can be increased when Edoxaban is combined with (S)-Warfarin.
4-hydroxycoumarin
Major
The risk or severity of bleeding can be increased when Edoxaban is combined with 4-hydroxycoumarin.
Abciximab
Major
The risk or severity of bleeding can be increased when Edoxaban is combined with Abciximab.
Acenocoumarol
Major
The risk or severity of bleeding can be increased when Edoxaban is combined with Acenocoumarol.
Savaysa Toxicity & Overdose RiskStopping edoxaban treatment before it is complete could lead to dangerous blood clots. Edoxaban also increases the risk of serious bleeding, such as bleeding in the brain or stomach. Patients need to be aware of signs of minor and major bleeding and know when to seek medical help. It is also important to avoid taking other blood thinners, anti-platelets, or clot-busting medications with edoxaban as this increases the risk of bleeding.
image of a doctor in a lab doing drug, clinical research

Savaysa Novel Uses: Which Conditions Have a Clinical Trial Featuring Savaysa?

61 active clinical trials are examining the potential of Savaysa in alleviating Stroke, Deep Vein Thrombosis (DVT) and Systemic Embolism.
Condition
Clinical Trials
Trial Phases
Systemic Embolism
2 Actively Recruiting
Not Applicable
Cerebrovascular accident prophylaxis
0 Actively Recruiting
Atrial Fibrillation
4 Actively Recruiting
Not Applicable
prophylaxis of systemic embolism
0 Actively Recruiting
Deep Vein Thrombosis
17 Actively Recruiting
Phase 4, Phase 3, Not Applicable, Phase 1, Phase 2
Stroke
11 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3
Pulmonary Embolism
35 Actively Recruiting
Not Applicable, Phase 4, Phase 3, Early Phase 1, Phase 1, Phase 2

Savaysa Reviews: What are patients saying about Savaysa?

5Patient Review
3/16/2016
Savaysa for Treatment to Prevent Blood Clots in Chronic Atrial Fibrillation
I bruises all over my body pretty easily, and this medication has made it much worse. I'm glad it will be out of my system in a week.
5Patient Review
6/19/2015
Savaysa for Treatment to Prevent Blood Clots in Chronic Atrial Fibrillation
4Patient Review
2/25/2018
Savaysa for Blood Clot in Lung
This drug helped thin my blood, but unfortunately I had to stop taking it because the side effect of kidney pain was too much to bear.
4Patient Review
12/12/2015
Savaysa for Treatment to Prevent Blood Clots in Chronic Atrial Fibrillation
3Patient Review
8/10/2016
Savaysa for Treatment to Prevent Blood Clots in Chronic Atrial Fibrillation
After starting this medication, my father-in-law developed congestive heart failure. Has anyone else experienced this side effect?
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about savaysa

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the side effects of Savaysa?

"Additionally, people may experience bleeding,, easy bruising,, nosebleeds,, rash,, abnormal liver function tests, and., low red blood cell count (anemia)."

Answered by AI

Is Savaysa an anticoagulant?

"Edoxaban is a pill taken once daily that helps reduce the risk of stroke and blood clots in people with nonvalvular atrial fibrillation. It can also be used to treat deep vein thrombosis and pulmonary embolism after initial treatment with a blood thinner given through an IV."

Answered by AI

What is the drug Savaysa used for?

"SAVAYSA can be used to treat blood clots in the veins of your legs or lungs after you have already been treated with an injectable blood thinner for 5 to 10 days."

Answered by AI

Is Savaysa the same as eliquis?

"Eliquis prevents blood clots from forming, while Savaysa can prevent blood clots from forming without any food restrictions or frequent blood tests. However, the effects of Savaysa will be very difficult to reverse if someone overdoses on the drug."

Answered by AI

Clinical Trials for Savaysa

Have you considered Savaysa clinical trials? We made a collection of clinical trials featuring Savaysa, we think they might fit your search criteria.
Have you considered Savaysa clinical trials? We made a collection of clinical trials featuring Savaysa, we think they might fit your search criteria.
Have you considered Savaysa clinical trials? We made a collection of clinical trials featuring Savaysa, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top